Thoracic Tumours and Head and Neck Cancer
The group is currently focusing on putting into practice ALK translocation, studying how effective PI3K/mTOR inhibitors are in patients with EGFR-TKI-resistant lung cancer, and studying how effective PARP inhibitors are in lung cancer.
They are analysing the epidemiological and clinical characteristics of women diagnosed with lung cancer. They are committed to reinforcing a multidisciplinary approach to provide the best care for patients, and are proactive in the fight against smoking.
9:00h a 20:00h